* STRATA Skin Sciences Inc SSKN.OQ reported a quarterly
adjusted
loss of 10 cents per share for the quarter ended in March,
lower than the same quarter last year, when the company reported
EPS of -8 cents. The mean expectation of two analysts for the
quarter was for a loss of 7 cents per share. Wall Street
expected results to range from -7 cents to -7 cents per share.
* Revenue fell 10.7% to $6.75 million from a year ago;
analysts
expected $6.91 million.
* STRATA Skin Sciences Inc's reported EPS for the quarter
was a
loss of 10 cents.
* The company reported a quarterly loss of $3.37 million.
* STRATA Skin Sciences Inc shares had risen by 1.3% this
quarter and lost 30.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 72.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is "buy."
Wall Street's median 12-month price target for STRATA Skin
Sciences Inc is $3.05
This summary was machine generated from LSEG data May 15 at
09:40 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.07 -0.10 Missed
Dec. 31 2023 -0.02 -0.11 Missed
Sep. 30 2023 -0.04 -0.03 Beat
Jun. 30 2023 -0.05 -0.06 Missed